ARTV · ISSUER CIK 1817241
Artiva Biotherapeutics, Inc.
Between Jul 31, 2026 and Oct 28, 2026, 6 Artiva Biotherapeutics, Inc. insiders reported $456K of open-market purchases and $2.0M of sales on SEC Form 4. The largest buyer was Ra Capital Management, L.P. (Director, 10% Owner), with $456K.
↗6 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 4 of 12 sales were reported under a 10b5-1 plan.
$456KInsider buying
$2.0MInsider selling
−$1.5MNet open-market
Oct 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202616:02 | Oct 6, 2026 | ARTV | Chief Executive Officer, Director | S · Sell10b5-1 | $7.20 | −23,463 | 1,519,606 | -2% | −$169K | ||
| Oct 6, 202616:02 | Oct 5, 2026 | ARTV | Chief Tech Operations Officer | S · Sell | $6.84 | −10,340 | 312,744 | -3% | −$71K | ||
| Oct 6, 202616:02 | Oct 5, 2026 | ARTV | COO, CLO, Compliance Officer | S · Sell | $6.84 | −8,370 | 366,159 | -2% | −$57K | ||
| Oct 6, 202616:02 | Oct 5, 2026 | ARTV | Chief Medical Officer | S · Sell | $6.84 | −1,099 | 169,848 | -1% | −$8K | ||
| Oct 6, 202616:01 | Oct 5, 2026 | ARTV | Chief Executive Officer, Director | S · Sell | $6.84 | −61,696 | 1,543,069 | -4% | −$422K | ||
| Sep 15, 202616:44 | Sep 15, 2026 | ARTV | Chief Executive Officer, Director | A · Grant | — | +110,000 | 1,604,765 | +7% | — | ||
| Sep 14, 202620:07 | Sep 10, 2026 | ARTV | Chief Executive Officer, Director | A · Grant | — | +45,000 | 1,494,765 | +3% | — | ||
| Sep 11, 202618:37 | Sep 9, 2026 | ARTV | President & Head of R&D | A · Grant | — | +45,000 | 122,500 | +58% | — | ||
| Sep 11, 202618:36 | Sep 9, 2026 | ARTV | Chief Tech Operations Officer | A · Grant | — | +40,000 | 323,084 | +14% | — | ||
| Sep 11, 202618:36 | Sep 9, 2026 | ARTV | COO, CLO, Compliance Officer | A · Grant | — | +45,000 | 374,529 | +14% | — | ||
| Sep 11, 202618:35 | Sep 9, 2026 | ARTV | Chief Medical Officer | A · Grant | — | +30,000 | 170,947 | +21% | — | ||
| Sep 9, 202616:02 | Sep 8, 2026 | ARTV | Chief Executive Officer, Director | S · Sell10b5-1 | $10.92 | −23,429 | 1,449,765 | -2% | −$256K | ||
| Sep 4, 202616:04 | Sep 3, 2026 | ARTV | Chief Tech Operations Officer | S · Sell | $11.16 | −10,366 | 283,084 | -4% | −$116K | ||
| Sep 4, 202616:03 | Sep 3, 2026 | ARTV | COO, CLO, Compliance Officer | S · Sell | $11.16 | −8,391 | 329,529 | -2% | −$94K | ||
| Sep 4, 202616:03 | Sep 3, 2026 | ARTV | Chief Medical Officer | S · Sell | $11.16 | −1,100 | 140,947 | -1% | −$12K | ||
| Sep 4, 202616:02 | Sep 3, 2026 | ARTV | Chief Executive Officer, Director | S · Sell | $11.16 | −61,888 | 1,473,194 | -4% | −$690K | ||
| Aug 31, 202619:06 | Aug 27, 2026 | ARTV | Chief Medical Officer | S · Sell10b5-1 | $12.01 | −8,222 | 142,047 | -5% | −$99K | ||
| Aug 31, 202619:06 | Aug 27, 2026 | ARTV | Chief Medical Officer | M · Exercise10b5-1 | $1.92 | +5,306 | 150,269 | +4% | $10K | ||
| Aug 19, 202621:00 | Aug 18, 2026 | ARTV | Chief Medical Officer | S · Sell10b5-1 | $12.00 | −429 | 144,963 | -0% | −$5K | ||
| Aug 19, 202621:00 | Aug 18, 2026 | ARTV | Chief Medical Officer | M · Exercise10b5-1 | $1.92 | +429 | 145,392 | +0% | $823.68 | ||
| Jul 31, 202617:13 | Jul 31, 2026from Jul 29, 2026 | ARTV | Director, 10% Owner · +5 joint | P · Buy | $9.96 | +45,768 | 17,329,570 | +0% | +$456K | -20.5% | -57.1% |